Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WorkCompWire
Article
WorkCompWire: Cathy Glade: Relieving the Adjuster's Burden Through Automated Technology
In her article, "Relieving the Adju
Workers' Comp
Article
Utilization Review: Addressing the Issues
Utilization review has received its share of criticism in workers’ compensation.
WorkCompWire
Article
WorkCompWire: Ron Skrocki: Medication Management: A Growing Problem Requiring a Collaborative Effort
In his article, "Medication Managem
Workers' Comp
White Paper
Reducing Human Error in Utilization Review Decision Making
Workers' Comp
News Release
Taking Heart in Workers' Comp
Genex honors three difference-making case management professionals through new Heart of Case Management AwardWAYNE, PA - April 11,
Workers' Comp
News Release
Making Better UR Decisions at the Desk Level
Genex brings together the heart and science of utilization review to extend overall medical quality